Kitov wins FDA approval for osteoarthritis drug

09:24 EDT 3 Jun 2018 | Globes

Kitov chairman: Consensi provides a safe and effective combination treatment option for the millions of Americans who suffer from osteoarthritis pain and hypertension.

Original Article: Kitov wins FDA approval for osteoarthritis drug

More From BioPortfolio on "Kitov wins FDA approval for osteoarthritis drug"